Monday 30 July 2012

Clinical Research Coordinator

Details: Virginia Cancer Specialists, affiliated with US Oncology, a leader in cancer care, has an exciting full time opportunity for an Clinical Research Coordinator in our Fairfax, VA.  office.Scope of position: Under direct supervision of a physician and nurse (if applicable), is responsible for enlisting, maintaining, and assuring protocol compliance for all patients on clinical trials. Collaborates with physician in determining eligibility of patients for clinical trials. Provides education to staff and patients. Ensures site research quality by practicing in compliance with US Oncology Research, Inc. (USOR) Standard Operating Procedures (SOP), principles of Good Clinical Practice (GCP) and applicable federal, state, and local regulations. Supports and adheres to US Oncology Compliance Program, to include the Code of Ethics Business Standards. ESSENTIAL DUTIES AND RESPONSIBILITIES: Screens potential patients for protocol eligibility. Presents trial concepts and details to the patients, participates in the informed consent process, and enrolls patients on protocol. Coordinates patient care in compliance with protocol requirements. In collaboration with the physician, reviews patients for changes in condition, adverse events, concomitant medication use, protocol compliance, response to study drug and thoroughly documents all findings. Responsible for accurate and timely data collection, documentation, entry, and reporting. Schedules and participates in monitoring and auditing activities. Maintains regulatory documents in accordance with USOR SOP and applicable regulations. May collaborate with Research Site Leader in the study selection process. Additional responsibilities may include working directly with other (non-USOR) research bases and/or sponsors. Provides a safe environment for patients, families, and clinical staff at all time through compliance with all federal, state, and professional regulatory standards as issued through OSHA and the CDC.

View the original article here

No comments:

Post a Comment